Journal of Acquired Immune Deficiency Syndromes (1999)
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.3 | Q3 | 39.0% | 1.066 | Q1 | 85.5% |
| 2024 | 2.2 | Q3 | 40.9% | 1.040 | Q1 | 85.3% |
| 2023 | 2.9 | Q2 | 60.0% | 1.225 | Q1 | 89.6% |
| 2022 | 3.6 | Q3 | 64.2% | 1.278 | Q1 | 90.9% |
| 2021 | 3.8 | Q3 | 64.2% | 1.469 | Q1 | 92.9% |
| 2020 | — | — | 2.162 | Q1 | 96.1% | |
| 2019 | — | — | 2.165 | Q1 | 96.2% | |
| 2018 | — | — | 2.624 | Q1 | 96.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1944-7884
ISSN
1525-4135
country
UScoverage
1988-1994, 1996-1997, 1999-2026